PCI Biotech to present at Bio€quity Europe
Oslo, Norway, May 18, 2017 – PCI Biotech (OSE:PCIB), a clinical-stage company developing innovative therapeutics that address significant unmet medical needs, today announced that it will present the Company at Bio€quity Europe, an investor and partnering event. The event is taking place at Paris Marriot Rive Gauche Conference Center, France, 22-23 May 2017. Dr. Per Walday, […]
First quarter 2017 report and presentation
Oslo, 16 May 2017 – Please find enclosed the financial report and presentation for first quarter 2017. PCI Biotech Q1 2017 Report PCI Biotech Q1 2017 Presentation Highlights fimaCHEM Presentation of the Phase I data at The International Liver Congress and the Annual Meeting of the US Cholangiocarcinoma Foundation Interaction with authorities to determine fastest […]
Notice of Annual General Meeting 2017
Oslo, 8 May 2017 – The shareholders of PCI Biotech Holding ASA are invited to attend the Annual General Meeting 2017 at Oslo Cancer Cluster Innovation Park. Time: Monday May 29, 10am CEST (local time). Venue: Jónas Einarsson aud. (2nd floor, entrance 2B), Oslo Cancer Cluster Innovation Park, Ullernchausséen 64, Oslo, Norway. Please find attached […]